Bruker Reports Q1 Results Ahead of Expectations, Reaffirms Full-Year Guidance
BRKR sits 35% above its 52-week low of $28.53.
Summary
Bruker Corporation announced first-quarter 2026 financial results, exceeding expectations despite organic revenue decline, and reconfirmed its full-year 2026 revenue and non-GAAP EPS guidance.
Key Events · Earnings and Guidance · BRKR
-
Q1 2026 Financial Performance
Reported Q1 2026 revenues of $823.4 million (up 2.7% year-over-year, down 4.4% organically) and non-GAAP diluted EPS of $0.31, with management noting performance was ahead of expectations.
-
Full-Year 2026 Guidance Reaffirmed
Reconfirmed previous FY2026 guidance for revenues of $3.57 to $3.60 billion (4-5% year-over-year growth) and non-GAAP EPS of $2.10 to $2.15 (15-17% year-over-year growth), signaling confidence despite Q1 organic decline.
-
Strong Bookings Trend
Bruker Scientific Instruments (BSI) segment bookings grew organically at a high-single digit percentage, with a book-to-bill ratio above 1.0x for the third consecutive quarter, indicating future revenue growth.
Analysis · BRKR · Industrial Applications And Services
Bruker Corporation announced first-quarter 2026 financial results, reporting revenues of $823.4 million, a 2.7% year-over-year increase, though organic revenue declined by 4.4%. GAAP diluted EPS was $0.02, while non-GAAP diluted EPS reached $0.31. Despite the organic revenue dip, management stated that financial performance came in ahead of expectations. Crucially, the company reconfirmed its full-year 2026 guidance, projecting revenues of $3.57 to $3.60 billion (4-5% year-over-year growth) and non-GAAP EPS of $2.10 to $2.15 (15-17% year-over-year growth). This reconfirmation, following a challenging 2025 with a net loss and impairment charges, provides a stabilizing signal. The Bruker Scientific Instruments (BSI) segment also reported high-single digit organic bookings growth and a book-to-bill ratio above 1.0x for the third consecutive quarter, indicating future revenue strength and a potential return to organic growth in Q2.
How filings like this one have moved
In the 30 days to Oct 1, 2026, 30.2% of the 1644 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.49%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, BRKR was trading at $38.50 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $5.8B. The 52-week trading range was $28.53 to $56.22. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.